id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1995-N-0029-0006,FDA,FDA-1995-N-0029,Small Entity Compliance Guides: Food Labeling; Nutrient Content Claims; Definition for High Potency and Definition of Antioxidant,Notice,NAD-Notice of Availability of Data,2008-07-18T04:00:00Z,2008,7,2008-07-18T04:00:00Z,,2024-11-12T04:17:23Z,E8-16448,1,0,09000064806835da
FDA-1995-N-0029-0009,FDA,FDA-1995-N-0029,"Food Labeling: Requirements for Nutrient Content Claims, Health Claims, and Statements of Nutritional Support for Dietary Supplements - Background Material",Supporting & Related Material,BKG-Background Material,2008-07-18T04:00:00Z,2008,7,,,2008-07-18T12:21:08Z,,0,0,090000648055a52f
FDA-1995-N-0029-0011,FDA,FDA-1995-N-0029,"Reference 3 - Memorandum [Levy] to Camille Brewer: Likely Effectiveness of Proposed Format Requirements for Disclaimer Statement on Dietary Supplement Products, January 16, 1997 - Background Material",Supporting & Related Material,BKG- Background Material (internal references),2008-07-18T04:00:00Z,2008,7,,,2008-07-18T12:21:09Z,,0,0,090000648062b0c2
FDA-1995-N-0029-0010,FDA,FDA-1995-N-0029,"Reference 2 - [Levy & Derby] The Impact of the NLEA on Consumer: Recent Findings from FDA’s Food Label and Nutrition Tracking System.” Executive Summary, January 23, 1996 - Background Material",Supporting & Related Material,BKG- Background Material (internal references),2008-07-18T04:00:00Z,2008,7,,,2008-07-18T12:21:08Z,,0,0,090000648062b056
FDA-1995-N-0029-0007,FDA,FDA-1995-N-0029,"The Office of Policy, RPMS to the Division of Dockets Management - Memorandum",Other,M-Memorandum,2008-07-18T04:00:00Z,2008,7,2008-07-18T04:00:00Z,,2008-07-18T12:20:56Z,,0,0,090000648055a4ba
FDA-1995-N-0029-0012,FDA,FDA-1995-N-0029,Guidance - GDL,Other,GDL-Guidance (Supporting and Related Materials),2008-07-18T04:00:00Z,2008,7,2008-07-18T04:00:00Z,,2008-07-18T12:25:26Z,,0,0,090000648068362d